Atlas Trials

Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

Clinical trial NCT06026371 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06026371
Sponsor
Fred Hutchinson Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
Start date
2023-12-12
Primary completion
2026-09-30
Enrollment
157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.